Comparative effects of dextrans, gelatin and stable plasma protein solution (SPPS) on the experimental disseminated intravascular coagulation (DIC).
D000818:Animals; D001772:Blood Cell Count; D001792:Blood Platelets; D001798:Blood Proteins / Q000627:therapeutic use*; D003911:Dextrans / Q000627:therapeutic use*; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy* / Q000209:etiology; D005337:Fibrin / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D005780:Gelatin / Q000627:therapeutic use*; D006168:Guinea Pigs / Q000276:immunology; D006494:Heparin Antagonists / Q000032:analysis; D007106:Immune Sera; D005779:Immunodiffusion; D008297:Male; D010973:Platelet Adhesiveness; D010974:Platelet Aggregation; D011817:Rabbits; D013917:Thrombin; D013925:Thromboplastin / Q000378:metabolism
D001798:Blood Proteins; D003911:Dextrans; D006494:Heparin Antagonists; D007106:Immune Sera; D005780:Gelatin; D005337:Fibrin; D005340:Fibrinogen; D013925:Thromboplastin; D013917:Thrombin; D005341:Fibrinolysin